A randomized study of epirubicin monotherapy every four or every two weeks in advanced breast cancer. A Hellenic Cooperative Oncology Group study von Fountzilas, G., Athanassiades, A., Giannakakis, T., Briasoulis, E., Bafaloukos, D., Kalogera-Fountzila, A., Onienaoum, A., Kalofonos, H., Pectasides, D., Andreopoulou, E., Bamia, C., Kosmidis, P., Pavlidis, N., Skarlos, D.

Volltext

Docetaxel and high-dose epirubicin as neoadjuvant chemotherapy in locally advanced breast cancer von ESPINOSA, E, MORALES, S, JANARIZ, J, DE LA PUENTE, M, CHECA, T, MEL, J. R, GONZALEZ BARON, M, BORREGA, P, CASAS, A, MADRONAL, C, MACHENGS, I, ILLARRAMENDI, J. A, LIZON, J, MORENO, J. A, BELON, J

Volltext

Dose-Dense Adjuvant Chemotherapy with Epirubicin Monotherapy in Patients with Operable Breast Cancer and ≥10 Positive Axillary Lymph Nodes von Fountzilas, George, Nicolaides, Costas, Aravantinos, Gerasimos, Skarlos, Dimosthenis, Kosmidis, Paris, Papakostas, Pavlos, Stathopoulos, George P., Kontostolis, Emmanouil, Bafaloukos, Dimitrios, Pavlidis, Nicholas

Volltext

Dose-dense adjuvant chemotherapy with epirubicin monotherapy in patients with operable breast cancer and ≥ 10 positive axillary lymph nodes : A feasibility study von FOUNTZILAS, G, NICOLAIDES, C, ARAVANTINOS, G, SKARLOS, D, KOSMIDIS, P, PAPAKOSTAS, P, STATHOPOULOS, G. P, KONTOSTOLIS, E, BAFALOUKOS, D, PAVLIDIS, N

Volltext

Fifteen-year trends in metastatic breast cancer survival in Greece von Dafni, U, Grimani, I, Xyrafas, A, Eleftheraki, A. G, Fountzilas, G

Volltext